Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

CLEMSON, S.C. - Nov. 18, 2020 - PRLog -- The "Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030" report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides. The study also features a detailed analysis of key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

§  A detailed review of the overall landscape of companies offering contract services for manufacturing of peptides.

§  An analysis on the recent developments in the industry, highlighting collaborations, facility expansions, and upcoming peptide synthesis technologies within this domain.

§  Informed estimates of the annual commercial and clinical demand for manufacturing peptides for therapeutic use.

§  A detailed analysis of more than 1,200 completed, ongoing and planned clinical trials of peptide therapeutics.

§  An estimate of the overall, installed capacity for manufacturing peptides, based on data reported by industry stakeholders in the public domain.

§  A discussion on regulatory guidelines related to peptide manufacturing, highlighting key differences across various geographies, various challenges, related to regulatory scrutiny, faced by peptide manufacturers.

§  Elaborate profiles of the key players that offer contract manufacturing services across different geographies, namely North America, Europe and Asia Pacific.

§  A discussion on industry affiliated trends, key drivers and challenges, under a SWOT framework.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

• Scale of Operation

§  Commercial

§  Preclinical / Clinical

• Type of Peptide Synthesis Method Used

§  Chemical

§  Non-Chemical

• Type of Peptide Chemical Synthesis Method Used

§  Liquid Phase Peptide Synthesis

§  Solid Phase Peptide Synthesis

§  Hybrid Phase Peptide Synthesis

• Type of End User

§  Small sized CMOs

§  Mid-sized CMOs

§  Large and very large sized CMOs

• Key Geographical Region

§  North America

§  Europe

§  Asia-Pacific and the Rest of the World

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html

Other Recent Offerings

1.   Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030 (https://www.rootsanalysis.com/reports/view_document/pepti...)

2.   China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.   Antibody Contract Manufacturing Market, 2020 - 2030

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com